Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2287]
News [5243]
Articles [128]
Editorials [4]
Conferences [157]
elearning [13]
INVICTUS: Assessing the safety and efficacy of ripretinib in patients with...
Prof Margaret von Mehren - Fox Chase Cancer Center, Philadelphia, USA
INVICTUS: Assessing the safety and efficacy of ripretinib in patients with advanced gastrointestinal stromal tumours ( Prof Margaret von Mehren - Fox Chase Cancer Center, Philadelphia, USA )
3 Oct 2019
Holistic management of patients with ALK-positive NSCLC
Rachel Thomas and Jackie Fenemore
Holistic management of patients with ALK-positive NSCLC ( Rachel Thomas and Jackie Fenemore )
3 Oct 2019
Precision medicine in ALK-positive NSCLC: Results from the BFAST trial
Prof Solange Peters and Prof Tony Mok
Precision medicine in ALK-positive NSCLC: Results from the BFAST trial ( Prof Solange Peters and Prof Tony Mok )
3 Oct 2019
Prostate cancer updates: Advances in precision medicine and PARP inhibitors
Prof Karim Fizazi, Dr Joaquin Mateo, Dr Shahneen Sandhu and Prof Bertrand Tombal
Prostate cancer updates: Advances in precision medicine and PARP inhibitors ( Prof Karim Fizazi, Dr Joaquin Mateo, Dr Shahneen Sandhu and Prof Bertrand Tombal )
2 Oct 2019
Health-related quality of life for patients with metastatic pancreatic cancer:...
Prof Eric Van Cutsem and Dr Teresa Macarulla
Health-related quality of life for patients with metastatic pancreatic cancer: Updates from ESMO 2019 ( Prof Eric Van Cutsem and Dr Teresa Macarulla )
2 Oct 2019
Key developments in pancreatic cancer from ESMO 2019
Prof Eileen O'Reilly and Dr Ian Chau
Key developments in pancreatic cancer from ESMO 2019 ( Prof Eileen O'Reilly and Dr Ian Chau )
2 Oct 2019
Breast cancer highlights from ESMO 2019
Dr Matteo Lambertini - San Martino Hospital, Genoa, Italy
Breast cancer highlights from ESMO 2019 ( Dr Matteo Lambertini - San Martino Hospital, Genoa, Italy )
2 Oct 2019
ClarIDHy: Targeted therapy ivosidenib for advanced cholangiocarcinoma
Prof Ghassan Abou-Alfa - Memorial Sloan Kettering Cancer Center, New York City...
ClarIDHy: Targeted therapy ivosidenib for advanced cholangiocarcinoma ( Prof Ghassan Abou-Alfa - Memorial Sloan Kettering Cancer Center, New York City, USA )
30 Sep 2019
Bladder cancer: Latest advances in targeted therapies and precision medicine...
Dr Javier Puente, Prof Maria De Santis, Dr Yohann Loriot, Dr Eva Comperat and...
Bladder cancer: Latest advances in targeted therapies and precision medicine from ESMO 2019 ( Dr Javier Puente, Prof Maria De Santis, Dr Yohann Loriot, Dr Eva Comperat and Dr Michiel Van der Heijden )
30 Sep 2019
PARP inhibitor olaparib slows progression of advanced prostate cancer
Prof Maha Hussain - Northwestern University Feinberg School of Medicine...
PARP inhibitor olaparib slows progression of advanced prostate cancer ( Prof Maha Hussain - Northwestern University Feinberg School of Medicine, Chicago, USA )
30 Sep 2019
Role of biomarkers, targeted therapy and tumour mutations in the landscape of...
Prof Petros Grivas and Dr Michiel Van der Heijden
Role of biomarkers, targeted therapy and tumour mutations in the landscape of bladder cancer ( Prof Petros Grivas and Dr Michiel Van der Heijden )
30 Sep 2019
Comment: PARP inhibitors for advanced prostate cancer
Dr Ignacio Duran - Hospital Universitario Virgen del Rocío, Sevilla, Spain
Comment: PARP inhibitors for advanced prostate cancer ( Dr Ignacio Duran - Hospital Universitario Virgen del Rocío, Sevilla, Spain )
30 Sep 2019

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation